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Abstract 
This paper focuses on presenting a case study of three cases of orbital 
myositis in one male and two female adult patients. All patients presented 
sudden loss of vision and proptosis at the initial stage. Ophthalmological 
examination outlined optic nerve atrophie. The diagnosis of all cases was 
confirmed with a CT scan  which showed specific muscle inflammation. The 
treatment was successfully carried out using bolus doses of corticosteroids 
relayed with oral prednisolone for over 6 weeks. Six (6) months follow-up, 
however, did not show any relapse in all the cases.   
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Introduction 
Orbital myositis (OM) is an inflammatory process affecting one or 
more oculomotor muscle and first merged with the term “Orbital pseudo-
tumor” in 1903 (Gleason, 1903). 
Orbital Myositis is mainly caused by non-thyroid inflammatory 
diseases; or it could be idiopathic. Vision is generally spared but in some rare 
cases, lowering of vision could be the alarming sign (Dubey et al., 2009). To 
the author’s knowledge, psychiatric symptom is not known to result from 
Orbital myositis. Thus, this study presents  reports of patients who were 
referred to an ophthalmology emergency clinic in Niamey, Niger, for 
proptosis associated to sudden visual loss.  
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Patients and Methods 
The study was carried out on 3 adult patients two females and one 
male- who were referred to the ophthalmology emergency clinic for proptosis 
and sudden loss of vision. 
 
Case No 1. 
Mr. M.A is a farmer of 55 years. He complained of low vision, painful 
eye movement and proptosis; all on the right eye. These symptoms were 
accompanied by a low grade fever. There was no past history of ocular or 
thyroid disease. On physical evaluation, he had a preserved general status, a 
fever of 39.9°C, blood pressure was 130/80, the pulse rate was 90 and a 
respiratory rate of 30. On external eye examination, there was a non axial 
(down and out) painful and reducible right eye grade 2 proptosis, and 
conjunctival chemosis. There was no light perception on the affected eye and 
the pupil was dilated with no response to light projection. When funduscopy 
was conducted, atrophic disc pallor was observed. The left eye was unaffected. 
Biological findings were hyperleukocytosis (14 000 WBC), elevated CRP 
level (76mg/dl), normal thyroid hormones levels: T3: 2.6 (2.50- 3.90umol/L); 
T4: 1.06 (0.85-1.76 ng/dL); TSH: 2.03 (0.27-4.68uIU/mL); anti-nuclear 
antibody level was normal (normal level 1:80); normal blood sugar 
(1.02mmol/l), Rheumatoid factors at 08 (≤ 14 IU/mL).  
The CT scan showed an important hypertrophy of superior rectus 
muscle with a normal optic nerve sheath (Figure 1). Its treatment was an 
association of intravenous antibiotics (cephalosporin of third generation) and 
corticosteroids (methyl-prednisolone a bolus stating dose and a daily dose of 
1mg/kg/day). Remission of proptosis was followed by a normalization of 
behaviour. A follow-up of about 6 months showed no actual relapse. 
        
Figure 1a and b. Enlarged superior rectus muscle belly (blue arrow) 
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Case No 2. 
Mrs. H.A is a 55 years old house wife who was transferred to the 
ophthalmology emergency clinic from the psychiatric ward for painful red left 
eye since about 10 days. She started having delirium and became violent 5 
days after the inception of pain and loss of vision on the left eye. She had no 
past history of psychiatric, ocular or thyroid disease. An ophthtalmoscopic 
examination revealed that the left eye visual acuity was of no light perception. 
External examination found a grade III proptosis associated to a complete 
ophthalmoplegia. Slit lamp examination out lined a conjunctival chemosis, 
dilated non reactive pupil, and an important disc pallor at funduscopy. The 
right eye had no abnormality. Biological check-up showed only an elevated 
CRP 100mg/dl, ESR 60 at first hour, while the thyroid hormones levels were 
normal (T3:3; T4 :1.5;  TSH: 3). CT scan of the orbit showed thickening of all 
the extra-ocular muscles (Figure 2). No auto-antibody was found. Its treatment 
was with a bolus dose of prednisolone, followed with a daily dose at 
1mg/kg/day. Treatment lasted six weeks and was followed up for 6 months 
with no relapse. Delirium was over after a week of treatment; proptosis was 
completely over but there was no visual recovery. 
 
Figure 2. Enlargement of extra-ocular muscles on left eye 
 
Case No 3. 
Mrs. A.A is a young lady of 22 years. She was referred from the 
endocrinology department for proptosis, lowering of sight and instable type 1 
diabetes. On examination, she had a visual acuity of light perception at the 
right eye and 10/10 at the left eye. External eye examination evidenced a 
limitation and painful movements of the rectus medial on the right side; while 
fundus examination showed a pale atrophic optic disc. Meanwhile, the left eye 
had no notable abnormality. CT scan evidenced an inflamed and enlarged 
rectus medial muscle, ESR level was elevated 65mg/dl, CRP 90 at first hour, 
and there was no auto antibodies found nor was there an elevated thyroid 
hormones (T3:2.9umol/L; T4:0.96ng/dL; TSH:2.8IU/mL). The diabetes was 
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difficult to stabilise and was, thus, placed on insulin pump. The treatment 
consisted of bolus doses of methyl-prednisolone for 3 days followed with oral 
hydrocortisone for over 4 weeks and, afterwards, gradual degressive doses for 
over 6 weeks. Remission was completed within 6 weeks of treatment with no 
remission till date. 
        
Figure 3 a and b. Enlarged medial rectus muscle 
 
Discussion 
Idiopathic orbital myositis (OM) is classified as a subtype of 
nonspecific orbital inflammation that usually involves the extra-ocular 
muscles (EOMs). It is seen mostly in young to middle-aged adults around 40 
years. (with range 7 to 80 years). There is an admitted ratio of 2 to 1 patients 
of orbital Myositis with female predominance. It is unanimously argued in the 
literature that females are more affected, as seen in this study (Hankey, 1937; 
Trokel et al., 1979; Dylewski, 2001; Byrne et al., 1992; Purcell et al., 1981; 
Espinoza et al., 2010; Smith et al., 1992; Sobrin et al., 2007). The rectus media 
is mostly affected. This is closely followed by the superior rectus and rarely 
oblique muscle (Trokel et al., 1979; Dylewski et al., 2001). The affection is 
mostly unilateral and many muscles could be affected at a time. Radiological 
images of affected muscles revealed the enlargement of muscle bellies along 
with thickened tendons (Byrne et al., 1992; Trokel et al., 1979). The etiology 
and pathogenesis of this entity is currently unknown. Both infectious and 
immune-mediated etiologies were implicated. Following streptococcal 
pharyngitis, orbital myositis as well as many other systemic diseases such as 
Crohn's disease,  rheumatoid arthritis, myasthenia gravis, and ankylosing 
spondylitis were reported by Purcell and Taulbee (Purcell et al., 1981; 
Espinoza et al., 2010; Woo et al., 2001). Mombaerts et al. (1997) found in their 
study that 10% of their patients with OM also had a concurrent autoimmune 
disease. Auto antibodies against oculomotor muscles had been reported by 
authors such as Atabay et al. (1995). However, these antibodies were also seen 
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in thyroid orbitopathy. Additionally, the typical unilateral presentation of OM 
argues against this type of autoimmunity as being the primary mechanism of 
OM (Atabay et al., 1995). Symptoms are mostly pain in adult and this occurs 
in 58-69% of patients, followed by diplopia at 31-38%; periorbital edema 
chemosis and proptosis have also been reported (Berger et al., 1996; Ding et 
al., 2011). Therefore, external examination of affected patients should 
emphasize on lid assessment for retraction/lid lag/lagophthalmos, orbital 
assessment (proptosis), extra-ocular muscles (restriction), globe 
(injection/chemosis), and optic nerve function (visual acuity/color 
plates/relative afferent pupillary defect). Vision is usually spared, progressive 
lowering, and, sometimes, total loss could be found (Gleason et al., 1903; 
Dubey et al., 2009). To the author’s knowledge, psychiatric manifestations 
following symptoms of idiopathic orbital myositis have not been reported in 
the literature. A satisfactory therapeutic consensus is lacking for this 
pathology. Other methods of treatment such as corticosteroid therapy, 
immunosuppressive drugs, radiotherapy and sometimes surgery were reported 
in the literature (Recai et al., 2011). Corticosteroid drugs at the dose of 1.0 to 
1.5mg/kg/d are the first line of treatment with quite a good response rate in 
most patients. This is the protocol we used in our cases with complete 
remission. Antimetabolites, such as azathioprine, methotrexate, 
mycophenolate mofetil are frequently used (Lacey  et al., 1999; Franzco et al., 
2006; Harris et al., 2006). Recently, the use of tumor necrosis factor, alpha 
blocker and new monoclonal antibodies were reported (Recai et al., 2011; 
Harris et al., 2006). In some severe cases, high dose of intravenous 
immunoglobulin or rituximab infusion may be helpful (Franzco et al., 2006; 
Recai et al., 2011; Lacey et al., 1999; Dalakas et al., 2006). 
 
Conclusion 
Orbital myositis is a rare affection of the extra-ocular muscles which 
is mostly idiopathic. Visual loss is rare and dramatic because it is irreversible. 
Corticosteroids are the first line of treatment even though there is no 
standardized line of treatment. Prompt corticotherapy and prolonged follow 
up may ameliorate the prognosis of this disease.  
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